Federal Supply Schedule 36F79724D0080
Award Date
7/15/24
Last Date to Order
7/14/29
Federal Agency
Veterans Integrated Service Network 12
Awardee
Adma Biologics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian agency, to Adma Biologics, Inc., a for-profit organization. The BPA has a total ceiling value of $49,000,000 and a period of performance running through July 31, 2025. The primary purpose of this BPA is to provide the federal government, particularly agencies within the Veterans Health Administration, with access to Adma Biologics' specialized pharmaceutical products, specifically ASCENIV and...
The Federal Supply Schedule (FSS) contract #36F79724D017E, awarded to Adma Biologics, Inc., provides the Department of Veterans Affairs (VA) and its Veterans Integrated Service Network 12 (VISN 12) with access to a variety of pharmaceutical and hematology-related products. The contract has a ceiling value of $25,000 and runs through July 14, 2024. Adma Biologics, a for-profit organization, specializes in plasma-derived therapeutics, with specific products referenced including ASCENIV and...
The Department of Veterans Affairs (VA) has awarded Amivas US LLC a five-year, $225,000 multiple-award Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB). This IDV allows VA medical facilities to issue task orders for Amivas' pharmaceuticals and hematology-related products. Amivas, a for-profit limited liability company, has prior experience providing pharmaceuticals and services related to clinical trials and medical research for federal agencies....
The U.S. Department of Veterans Affairs (VA) has awarded a single-award Blanket Purchase Agreement (BPA) to Ferring Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The $5.96 million BPA, with a period of performance through March 2026, enables the VA to procure the drug Adstiladrin (nadofaragene firadenovec), a treatment for genitourinary cancers, to support the provision of healthcare services to...
The Federal Supply Schedule contract award to Aadi Bioscience, Inc. is for pharmaceutical, drug, and hematology-related products under Special Item Number (SIN) 65 I B. The $300,000.00 ceiling value contract was awarded on August 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a period of performance through July 31, 2027. As a multiple award Federal Supply Schedule contract, this vehicle allows federal...
The U.S. Department of Veterans Affairs (VA) has awarded a $1.7M Federal Supply Schedule (FSS) contract to Amneal Pharmaceuticals of New York, LLC, a for-profit limited liability company that manufactures pharmaceutical products. The FSS contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, enables the VA to procure a variety of drugs, pharmaceuticals, and hematology-related products from Amneal through task orders over the 5-year contract period. Separately, the VA has also...
The federal contract IDV award is for a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for "65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS." The prime contractor is Kamada Inc., a foreign-owned for-profit organization. The contract has a ceiling value of $750,000.00 and a period of performance from July 1, 2024 to June 30, 2029. The contract was awarded without any set-asides and is a multiple award. As an FSS contract, it...
This Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to ADC Therapeutics America, Inc. procures a range of pharmaceutical and hematology-related products. The $540,000.00 contract, which runs from October 1, 2021 through September 30, 2026, is part of the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule and does not utilize any set-asides. As a multiple award contract, the VA can place task orders against this vehicle to acquire the specified drug...
The National Acquisition Center, a civilian agency of the Department of Veterans Affairs (VA), has awarded a single-award Blanket Purchase Agreement (BPA) to Bio Products Laboratory LIMITED, a for-profit manufacturer of pharmaceutical goods. The BPA, valued at up to $1,125,000 over a base year with four one-year option periods through April 2026, is for the procurement of ALBUMINEX albumin products to be delivered to VA medical facilities nationwide. This BPA is established under the VA's...
The Department of Veterans Affairs (VA) awarded Amgen USA Inc., a division of the biotechnology company Amgen Inc., a $3.372 billion Federal Supply Schedule (FSS) contract (36F79721D0086) for the provision of pharmaceuticals, drugs, and hematology-related products. This multiple-award IDV under the GSA Pharmaceuticals and Drugs (FSS-61-IB) schedule allows Amgen to supply these products to various federal agencies. Under this IDV, the VA has issued a $65,478.18 Firm Fixed Price delivery order...